Enteral Feeding Study of Formula Containing Fish Oil in Critical Care Setting
- Conditions
- Tube FeedingTrauma
- Registration Number
- NCT00421941
- Lead Sponsor
- Société des Produits Nestlé (SPN)
- Brief Summary
The purpose of this study is to evaluate the clinical applicability of an enteral tube feeding formula containing fish oil and prebiotics in a critical care population.
- Detailed Description
In terms of nutrition support in the acute care setting, it is generally accepted that
1. earlier is better
2. enteral is superior to parenteral
3. the quality of nutrients appears more important than quantity
4. select populations will show additional benefit from specific nutrient supplementation.
The current study is designed to evaluate the tolerance of an enteral formula in trauma and surgery patients, as demonstrated by achieving and maintaining enteral feeding goal, gastrointestinal tolerance and inflammatory markers.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 50
- 18 - 70 years old
- New ICU admit
- Enteral tube feeding anticipated for at least 7 days
- Informed consent
- Enteral tube feeding immediately prior to admit
- Parenteral feeding
- Medical condition that preclude receiving tube feeding or formula
- Determined by PI to be inappropriate
- Participating in another clinical trial
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Clinical applicability as measured by the length of time between start of feeding to the first achievement of 800ml/day
- Secondary Outcome Measures
Name Time Method Gastrointestinal tolerance Time to advance to full feed Inflammatory markers Infection
Trial Locations
- Locations (1)
Oregon Health & Science University
🇺🇸Portland, Oregon, United States
Oregon Health & Science University🇺🇸Portland, Oregon, United States